Status:
COMPLETED
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Type 1 Diabetes
Hypoglycemia
Eligibility:
All Genders
5-21 years
Phase:
NA
Brief Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptak...
Eligibility Criteria
Inclusion
- Diagnosis of Type 1 diabetes for \>3 months
Exclusion
- CGM use in the last 6 months
Key Trial Info
Start Date :
January 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04721145
Start Date
January 25 2021
End Date
June 28 2022
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, United States, 21287